Year archive

AstraZeneca PLC — 2024 filings

All 214 regulatory filings released by AstraZeneca PLC (AZN) in 2024, sourced directly from the official regulator.

214 Filings

2024 Period

2024 filings (214)

Filing	Released	Lang
DATO-DXD NSQ NSCLC APPLICATION WITHDRAWN IN EU Foreign Filer Report	2024-12-26	English
Dato-DXd NSQ NSCLC application withdrawn in EU Regulatory Filings	2024-12-24	English
TAGRISSO APPROVED IN EU BASED ON LAURA TRIAL Foreign Filer Report	2024-12-23	English
Tagrisso approved in EU based on LAURA trial Legal Proceedings Report	2024-12-23	English
DIRECTORATE CHANGE Foreign Filer Report	2024-12-16	English
Directorate Change Board/Management Information	2024-12-16	English
IMFINZI APPROVED IN US FOR LIMITED-STAGE SCLC Foreign Filer Report	2024-12-05	English
Imfinzi approved in US for limited-stage SCLC Regulatory Filings	2024-12-05	English
ASTRAZENECA APPOINTS ISKRA REIC EVP INTERNATIONAL Foreign Filer Report	2024-12-04	English
AstraZeneca appoints Iskra Reic EVP International Board/Management Information	2024-12-04	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2024-12-02	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-12-02	English
Block listing Interim Review Share Issue/Capital Change	2024-12-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-12-02	English
TRUQAP IMPROVED RPFS IN ADVANCED PROSTATE CANCER Foreign Filer Report	2024-11-25	English
Truqap improved rPFS in advanced prostate cancer Regulatory Filings	2024-11-25	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-11-20	English
Director/PDMR Shareholding Director's Dealing	2024-11-20	English
TAGRISSO RECOMMENDED FOR EU APPROVAL - LAURA Foreign Filer Report	2024-11-18	English
Tagrisso recommended for EU approval - LAURA Regulatory Filings	2024-11-18	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-11-15	English
Director/PDMR Shareholding Director's Dealing	2024-11-15	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-11-15	English
Director/PDMR Shareholding Director's Dealing	2024-11-15	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-11-13	English
Director/PDMR Shareholding Director's Dealing	2024-11-13	English
ASTRAZENECA INVESTS $3.5 BILLION IN US Foreign Filer Report	2024-11-12	English
KOMET PHASE III TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2024-11-12	English
9M AND Q3 2024 RESULTS Foreign Filer Report	2024-11-12	English
DATO-DXD NEW BLA SUBMITTED, NSQ BLA WITHDRAWN Foreign Filer Report	2024-11-12	English
AstraZeneca invests $3.5 billion in US Regulatory Filings	2024-11-12	English
KOMET Phase III trial met primary endpoint Regulatory Filings	2024-11-12	English
9M and Q3 2024 Results Interim / Quarterly Report 9M 2024	2024-11-12	English
Dato-DXd new BLA submitted, NSQ BLA withdrawn Regulatory Filings	2024-11-12	English
TEZSPIRE NASAL POLYPS TRIAL MET PRIMARY ENDPOINTS Foreign Filer Report	2024-11-08	English
Tezspire nasal polyps trial met primary endpoints Regulatory Filings	2024-11-08	English
AZN share price movement Regulatory Filings	2024-11-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-11-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-11-01	English
AZN CHINA PRESIDENT UNDER INVESTIGATION Foreign Filer Report	2024-10-30	English
AZN China President under investigation Legal Proceedings Report	2024-10-30	English
SC 13G Major Shareholding Notification	2024-10-28	English
FORM 6-K Foreign Filer Report	2024-10-21	English
Wainzua recommended for approval in the EU Legal Proceedings Report	2024-10-21	English
SC 13G Major Shareholding Notification	2024-10-11	English
ASTRAZENECA LICENSES LIPID LOWERING LP(A) ASSET Foreign Filer Report	2024-10-07	English
AstraZeneca licenses lipid lowering Lp(a) asset Regulatory Filings	2024-10-07	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-10-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-10-01	English
TAGRISSO US APPROVAL IN UNRESECTABLE LUNG CANCER Foreign Filer Report	2024-09-26	English
Tagrisso US approval in unresectable lung cancer Regulatory Filings	2024-09-26	English
FASENRA RECOMMENDED FOR EU APPROVAL IN EGPA Foreign Filer Report	2024-09-23	English
FINAL OS RESULTS REPORTED FOR TROPION - BREAST01 Foreign Filer Report	2024-09-23	English
Fasenra recommended for EU approval in EGPA Regulatory Filings	2024-09-23	English
Final OS results reported for TROPION-Breast01 Regulatory Filings	2024-09-23	English
FLUMIST APPROVED FOR SELF-ADMINISTRATION IN US Foreign Filer Report	2024-09-20	English
FluMist approved for self-administration in US Regulatory Filings	2024-09-20	English
FASENRA EGPA US FDA APPROVAL Foreign Filer Report	2024-09-18	English
Fasenra EGPA US FDA approval Regulatory Filings	2024-09-18	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-09-13	English
Director/PDMR Shareholding Director's Dealing	2024-09-13	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-09-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-09-02	English
IMFINZI APPROVED IN US FOR RESECTABLE LUNG CANCER Foreign Filer Report	2024-08-16	English
Imfinzi approved in US for resectable lung cancer Regulatory Filings	2024-08-16	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-08-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-08-01	English
AstraZeneca PLC;AstraZeneca Finance LLC - Supplementary Prospectus Capital/Financing Update	2024-07-30	English
ASTRAZENECA PRICES A EUR1.4BN BOND OFFERING Foreign Filer Report	2024-07-30	English
AstraZeneca prices a €1.4bn bond offering Capital/Financing Update	2024-07-30	English
CALQUENCE FIXED-DURATION COMBO IMPROVED 1L CLL PFS Foreign Filer Report	2024-07-29	English
Calquence fixed-duration combo improved 1L CLL PFS Earnings Release Q3 2024	2024-07-29	English
ODAC REVIEWED IMFINZI IN RESECTABLE LUNG CANCER Foreign Filer Report	2024-07-26	English
ODAC reviewed Imfinzi in resectable lung cancer Regulatory Filings	2024-07-26	English
FORM 6K Foreign Filer Report	2024-07-25	English
Half-year Report Earnings Release H1 2024	2024-07-25	English
ACQUISITION OF AMOLYT PHARMA COMPLETED Foreign Filer Report	2024-07-15	English
Acquisition of Amolyt Pharma completed Regulatory Filings	2024-07-15	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-07-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-07-01	English
LYNPARZA & IMFINZI POSITIVE CHMP IN ENDOMETRIAL Foreign Filer Report	2024-07-01	English
Lynparza & Imfinzi positive CHMP in endometrial Regulatory Filings	2024-07-01	English
ANNUAL REPORT Regulatory Filings	2024-06-26	English
UPDATE ON IMFINZI ADJUVANT BR.31 TRIAL Foreign Filer Report	2024-06-25	English
IMFINZI IMPROVED EFS AND OS IN BLADDER CANCER Foreign Filer Report	2024-06-25	English
Update on Imfinzi ADJUVANT BR.31 trial Regulatory Filings	2024-06-25	English
Imfinzi improved EFS and OS in bladder cancer Legal Proceedings Report	2024-06-25	English
UPDATE ON CAPITELLO-290 PHASE III TRIAL Foreign Filer Report	2024-06-18	English
Update on CAPItello-290 Phase III trial Regulatory Filings	2024-06-18	English
IMFINZI APPROVED IN THE US FOR ENDOMETRIAL CANCER Foreign Filer Report	2024-06-17	English
AstraZeneca PLC;AstraZeneca Finance LLC - Base prospectus (debt) Capital/Financing Update	2024-06-17	English
Imfinzi approved in the US for endometrial cancer Regulatory Filings	2024-06-17	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-06-12	English
Director/PDMR Shareholding Director's Dealing	2024-06-12	English
Acquisition of Fusion completed M&A Activity	2024-06-05	English
FORM 6-K Foreign Filer Report	2024-06-04	English
Delisting Announcement 2024 Delisting Announcement	2024-06-04	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2024-06-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-06-03	English
Block listing Interim Review Remuneration Information	2024-06-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-06-03	English
TAGRISSO PLUS CHEMO RECOMMENDED FOR APPROVAL IN EU Foreign Filer Report	2024-06-03	English
Tagrisso plus chemo recommended for approval in EU Regulatory Filings	2024-06-03	English
DATO-DXD IMPROVED OS IN NONSQUAMOUS LUNG CANCER Foreign Filer Report	2024-05-28	English
Dato-DXd improved OS in nonsquamous lung cancer Regulatory Filings	2024-05-28	English
ASTRAZENECA TO DELIVER $80BN REVENUE BY 2030 Foreign Filer Report	2024-05-21	English
AstraZeneca to deliver $80bn revenue by 2030 Earnings Release Q1 2024	2024-05-21	English
ASTRAZENECA TO MANUFACTURE ADCS IN SINGAPORE Foreign Filer Report	2024-05-20	English
AstraZeneca to manufacture ADCs in Singapore Regulatory Filings	2024-05-20	English
SUPERNOVA TRIAL MET COVID-19 PREVENTION ENDPOINT Foreign Filer Report	2024-05-16	English
SUPERNOVA Trial Met COVID-19 prevention endpoint Regulatory Filings	2024-05-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-05-15	English
Director/PDMR Shareholding Director's Dealing	2024-05-15	English
ASTRAZENECA COMPLETES CELLECTIS EQUITY INVESTMENT Foreign Filer Report	2024-05-07	English
AstraZeneca completes Cellectis equity investment Share Issue/Capital Change	2024-05-07	English
CALQUENCE COMBINATION IMPROVED PFS IN 1L MCL Foreign Filer Report	2024-05-02	English
Calquence combination improved PFS in 1L MCL Regulatory Filings	2024-05-02	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-05-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-05-01	English
TRUQAP RECOMMENDED FOR EU BREAST CANCER APPROVAL Foreign Filer Report	2024-04-29	English
ENHERTU IMPROVED PFS IN HER2-LOW AND ULTRALOW Foreign Filer Report	2024-04-29	English
Truqap recommended for EU breast cancer approval Legal Proceedings Report	2024-04-29	English
Enhertu improved PFS in HER2-low and ultralow Earnings Release Q2 2024	2024-04-29	English
1ST QUARTER RESULTS Foreign Filer Report	2024-04-25	English
1st Quarter Results Earnings Release Q1 2024	2024-04-25	English
Special Business Approved at AGM AGM Information	2024-04-12	English
RESULT OF AGM Foreign Filer Report	2024-04-11	English
Result of AGM AGM Information	2024-04-11	English
ASTRAZENECA INCREASES 2024 DIVIDEND BY 7% Foreign Filer Report	2024-04-11	English
AstraZeneca increases 2024 dividend by 7% Notice of Dividend Amount	2024-04-11	English
ENHERTU APPROVED IN US FOR HER2+ SOLID TUMOURS Foreign Filer Report	2024-04-08	English
Enhertu approved in US for HER2+ solid tumours Regulatory Filings	2024-04-08	English
IMFINZI IMPROVED OS & PFS IN LIMITED-STAGE SCLC Foreign Filer Report	2024-04-05	English
Imfinzi improved OS & PFS in limited-stage SCLC Earnings Release Q2 2024	2024-04-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-04-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-04-02	English
VOYDEYA APPROVED IN US Foreign Filer Report	2024-04-02	English
FDA ACCEPTS DATO-DXD BLA FOR BREAST CANCER Foreign Filer Report	2024-04-02	English
Voydeya approved in US Regulatory Filings	2024-04-02	English
FDA accepts Dato-DXd BLA for breast cancer Regulatory Filings	2024-04-02	English
ULTOMIRIS APPROVED IN THE US FOR NMOSD Foreign Filer Report	2024-03-25	English
Ultomiris approved in the US for NMOSD Regulatory Filings	2024-03-25	English
DFAN14A Proxy Solicitation & Information Statement	2024-03-19	English
F-3ASR Regulatory Filings	2024-03-19	English
FORM 6-K Foreign Filer Report	2024-03-19	English
AstraZeneca to acquire Fusion M&A Activity	2024-03-19	English
ASTRAZENECA TO ACQUIRE AMOLYT Foreign Filer Report	2024-03-14	English
AstraZeneca to acquire Amolyt M&A Activity	2024-03-14	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-03-12	English
Director/PDMR Shareholding Director's Dealing	2024-03-12	English
FORM 6-K Foreign Filer Report	2024-03-07	English
NOTICE OF AGM Foreign Filer Report	2024-03-07	English
PSP share plan rules - for shareholder approval at 2024 AGM Remuneration Information	2024-03-07	English
Proxy Form for 2024 AGM AGM Information	2024-03-07	English
Notice of AGM AGM Information	2024-03-07	English
Notice of AGM AGM Information	2024-03-07	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-03-06	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-03-06	English
Director/PDMR Shareholding Director's Dealing	2024-03-06	English
Director/PDMR Shareholding Remuneration Information	2024-03-06	English
Regulatory Filings 2024 Regulatory Filings	2024-03-06	English
8-A12B Regulatory Filings	2024-03-05	English
EMA VALIDATES DATO-DXD MAAS FOR NSQ NSCLC AND BC Foreign Filer Report	2024-03-04	English
EMA validates Dato-DXd MAAs for NSQ NSCLC and BC Regulatory Filings	2024-03-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-03-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-03-01	English
FORM 6-K Foreign Filer Report	2024-02-26	English
VOYDEYA RECOMMENDED FOR EU APPROVAL Foreign Filer Report	2024-02-26	English
Voydeya recommended for EU approval Regulatory Filings	2024-02-26	English
424B2 Prospectus	2024-02-23	English
ASTRAZENECA PRICES A $5BN BOND OFFERING Foreign Filer Report	2024-02-22	English
FORM 6-K Foreign Filer Report	2024-02-22	English
Acquisition of Gracell completed Regulatory Filings	2024-02-22	English
AstraZeneca PLC;AstraZeneca Finance LLC - Supplementary Prospectus Capital/Financing Update	2024-02-22	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-22	English
Director/PDMR Shareholding Director's Dealing	2024-02-22	English
AstraZeneca prices a $5bn bond offering Capital/Financing Update	2024-02-22	English
FWP Regulatory Filings	2024-02-22	English
424B2 Prospectus	2024-02-21	English
FILING OF FORM 20-F WITH SEC Foreign Filer Report	2024-02-21	English
Filing of Form 20-F with SEC Report Publication Announcement	2024-02-21	English
SC TO-T/A Filing Regulatory Filings	2024-02-21	English
FORM S-8 Registration Form	2024-02-20	English
IRANNOTICE Regulatory Filings	2024-02-20	English
FORM 20-F Annual Report FY 2023	2024-02-20	English
FORM 6-K Foreign Filer Report	2024-02-20	English
ANNUAL FINANCIAL REPORT Foreign Filer Report	2024-02-20	English
FORM 6-K Foreign Filer Report	2024-02-20	English
ASTRAZENECA COMPLETES ACQUISITION OF ICOSAVAX Foreign Filer Report	2024-02-20	English
TAGRISSO PLUS CHEMO APPROVED IN US FOR LUNG CANCER Foreign Filer Report	2024-02-20	English
FDA ACCEPTS DATO-DXD BLA FOR NONSQUAMOUS NSCLC Foreign Filer Report	2024-02-20	English
TAGRISSO IMPROVED PFS IN STAGE III LUNG CANCER Foreign Filer Report	2024-02-20	English
AstraZeneca PLC Annual Report & 20-F Information 2023 Annual Report (ESEF) FY 2023	2024-02-20	English
AstraZeneca PLC Annual Report & 20-F Information 2023 Annual Report FY 2023	2024-02-20	English
Annual Financial Report Report Publication Announcement	2024-02-20	English
Annual Report (ESEF) 2023 Annual Report (ESEF) FY 2023	2024-02-20	English
SC TO-T/A Filing Regulatory Filings	2024-02-20	English
AstraZeneca completes acquisition of Icosavax Delisting Announcement	2024-02-19	English
Tagrisso plus chemo approved in US for lung cancer Legal Proceedings Report	2024-02-19	English
FDA accepts Dato-DXd BLA for nonsquamous NSCLC Regulatory Filings	2024-02-19	English
Tagrisso improved PFS in Stage III lung cancer Regulatory Filings	2024-02-19	English
SC TO-T/A Filing Regulatory Filings	2024-02-15	English
SC 13G/A Major Shareholding Notification	2024-02-12	English
FINAL RESULTS Foreign Filer Report	2024-02-08	English
Final Results Earnings Release Q4 2023	2024-02-08	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-02-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-02-01	English
Major Shareholding Notification 2024 Major Shareholding Notification	2024-01-24	English
FORM 6-K Foreign Filer Report	2024-01-19	English
SC TO-T/A Filing Regulatory Filings	2024-01-19	English
Regulatory Filings 2024 Regulatory Filings	2024-01-11	English
SC TO-T/A Filing Regulatory Filings	2024-01-11	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-01-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-01-02	English

Filings by year

2026 85 filings
2025 244 filings
2024 214 filings
2023 196 filings
2022 252 filings
2021 318 filings
2020 306 filings
2019 250 filings
2018 226 filings
2017 189 filings
2016 207 filings
2015 192 filings
2014 352 filings
2013 195 filings
2012 42 filings
2011 19 filings
2010 17 filings